USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR INCREASING RADIOSENSITVITY IN THE TREATMENT OF A BRAIN TUMOUR

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160136127A1
SERIAL NO

14899598

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer. Preferably the phytocannabinoids used are either tetrahydrocannabinol (THC) and/or cannabidiol (CBD). Preferably the type of cancer to be treated is glioma.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GW PHARMA LIMITEDPORTON DOWN SCIENCE PARK SALISBURY WILTSHIRE SP4 0JQ

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DALGLEISH, Angus London, GB 25 36
DUNCAN, Marnie Salisbury, Wiltshire, GB 6 77
LIU, Wai London, GB 24 56
SCOTT, Katherine London, GB 7 509
STOTT, Colin Salisbury, Wiltshire, GB 22 689

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation